中国（武汉）地区应用慢性缺血性心脏病的ICF核心功能组合的研究

目的：研究适应中国（武汉）地区慢性缺血性心脏病（CHID）患者的简明国际功能、残疾与健康分类（ICF）的核心功能组合类目，使其能广泛应用于临床医疗实践、为CIHD患者健康状况的测量提供可靠的依据。方法：使用CIHD的ICF调查表同时对58例CIHD患者和32名心血管以及康复专家做面访或电邮调查，统计CIHD患者出现明显问题的频率和专家一致认为有显著意义的类目的频率。结果：得到患者阳性率≥30％的ICF类目30个，专家组意见显著性≥50％的ICF类目22个，合计得到具有显著性意义的ICF核心功能组合类目共有37个，其中身体功能13个，身体结构2个，活动与参与8个，环境因素14个。结论：本次研究所得的简明核心功能组合类目与已报道的简明ICF核心功能组合类目相比一致性较好，地域、调查对象等因素的影响也能对少数有差别的类目进行很好的解释，尚有部分类目确定有待更大样本的再次检验。

Application of International Classification of Functioning, Disability and Health for Chronic Ischemic Heart Disease in Wuhan, China

Objective： To determine the categories of the brief International Classification of Functioning, Disability and Health （ICF） Core Set for Chronic Ischemic Heart Disease （CIHD） in Wuhan, China, to apply the classification in extensive clinical practice and research, and to provide the basis for predicting need of condition-specific healthstatus measures using the brief ICF Core Set. Methods： Fifty-eight patients with CIHD were interviewed and 32 questionnaires were replied by cardiovascular and rehabilitation experts who had been interviewed or receive the Email with the expanded ICF Core Set for CIHD that had been used to examine the frequency of patients＇ problems and consensus of experts＇ agreement in the specific population. Results： Thirty categories of ICF with a frequency over 30 % for patients with CIHD and 22 categories of ICF with a frequency over 50 % for experts were identified. Altogether 37 categories were included in the brief ICF Core Sets for CIHD with 13 categories from the component body functions, 2 from body structures, 8 from activities and participation, and 14 from environmental factors. Conclusion： To compare with the first version of the brief ICF Core Sets for CIHD, the version of brief ICF Core Sets for Chinese patients with CIHD in this study showed considerable similarity. Some discriminatory categories could be elucidated by different countries, socio-eeonomic factors （age, gender and other variables） , disease characteristics （disease severity and activity）, disease duration, and eomorbidities, etc.